Nexavar
Active substance: sorafenib
sorafenib
Centralised EU authorisationActive
Marketing holder: Bayer AG
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 22 |
|
| US 6 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-357b-71ec-86a2-5da1b63017f1,01a120c3-3b2c-7f10-b015-d23d53d6addc,01a120c3-3b3c-7f00-ae07-1e1fa9257d9a,01a120c3-4f18-7b99-9286-ebd042f8a308,01a120c3-5e3c-7207-b9c9-b35cb311800f;count=19 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-6c51-7272-8144-cd905253e1f1,01a1208e-0425-7a1a-a3d0-876aeea28228,01a1208e-6145-7b6c-99e8-4d0dd09e71ae,01a12091-c981-796d-befc-b8152e8f98bd,01a12095-86b1-7c3d-90ce-b55db82a1f19;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/000690
- Registration status
- Active
- ATC code
- L01EX02
Sources
- product · EMA · EMEA/H/C/000690 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000690 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000690 · Verified 2026-10-09